|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/445 | |
| A61P 13/08 |
| (11) | Number of the document | 2222301 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08859451.0 |
| Date of filing the European patent application | 2008-12-13 | |
| (97) | Date of publication of the European application | 2010-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/086733 |
| Date | 2008-12-13 |
| (87) | Number | WO 2009/076663 |
| Date | 2009-06-18 |
| (30) | Number | Date | Country code |
| 13375 | 2007-12-13 | US |
| (72) |
POLYMEROPOULOS, Mihael, H., US
BAROLDI, Paolo, US
WOLFGANG, Curt, D., US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037,
US
|
| (54) | METHOD AND COMPOSITION FOR TREATING AN ALPHA ADRENOCEPTOR-MEDIATED CONDITION |
| METHOD AND COMPOSITION FOR TREATING AN ALPHA ADRENOCEPTOR-MEDIATED CONDITION |